Dear Editor, We read with great interest the article by Durlinger and colleagues associating a threshold peripheral oxygen saturation (SpO 2 ) level of >96% with arterial hyperoxia (PaO 2 >125 mmHg) [1] . Given the continuous nature of SpO 2 monitoring, we agree it is important to identify clinically appropriate targets of SpO 2 to guide the clinician in their practice. Although we appreciate this is a small prospectively collected sample, we ask the authors whether any outcome differences were seen between patients with SpO2 levels above and below 96%. Both de Jonge and Helmerhort et al have shown a U-shaped curve of harm related to admission PaO 2 in adult patients [2, 3] . They demonstrated a nadir of risk associated with a PaO 2 of 100-200 mmHg. Therefore a cut-off of 125 mmHg may be too low a threshold for hyperoxia.
Preliminary work in children is similar [4] .
The determinants of haemoglobin oxygen affinity (pH, temperature, CO 2 , 2,3 DPG and fetal haemoglobin) may vary with critical illness. Hence large, heterogeneous datasets may be required to refine our estimate of PaO2 from SpO2 thresholds. As part of our clinical studies into the value of permissive hypoxaemia we re-analysed our dataset of blood gas and SpO 2 values collected from children transported to paediatric intensive care over a 3 year period (n=2128 in 1541 children) [5] . The relationship between We accept that these values may represent extremes of the population distribution, and may be secondary to a higher fetal haemoglobin fraction in children. Nevertheless, from this large cohort, we have confirmed the wide variability of PaO 2 values for each SpO 2 and therefore we question the reliability of inferring 'safe' SpO 2 thresholds from these values. Rather, we propose that 'safe' SpO 2 levels should be defined by randomised controlled trials comparing liberal versus conservative SpO 2 targets -as piloted by Panwar et al in adults, and currently undertaken in children by our group (Oxy-PICU, clinicaltrials.gov NCT03040570) [6] .
